Abstract
Discovery of LHRH1,2 and the availability of its potent agonistic analogues has led to a rapid increase in our knowledge of the pituitary-gonadal axis and has offered new and exciting therapeutic approaches in reproductive endocrinology as well as in sex steroid-dependent diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Matsuo, H., Baba, Y., Nair, R. M. G., Arimura, A. and Schally, A. V. (1971). Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem. Biophys. Res. Commun., 43, 1334
Burgus, R., Butcher, M., Ling, N., et al. (1971). Structure moléculaire du facteur hypothalamique (LRF) d’origine ovine contrôlant la sécrétion de l’hormone gonadotrope hypophysaire. C. R. Acad. Sci. ID (Paris), 273, 1611
Schwartzstein, L. (1976). Diagnostic and therapeutic use of LHRH in the infertile man. In Labire, F., Meites, J. and Pelletier, G. (eds.). Hypothalamus and Endocrine Functions, pp. 73–91. ( New York: Plenum Press )
Krabbe, S. and Shakkeback, N. E. (1977). Gonadotropin-releasing hormone (LHRH) and human chorionic gonadotropin in the treatment of two boys with hypogonadotrophic hypogonadism. Acta Paediatr. Scand., 66, 361
Auclair, C., Kelly, P. A., Labrie, F., Coy, D. H. and Schally, A. V. (1977). Inhibition of testicular luteinizing hormone receptor levels by treatment with a potent luteinizing hormone-releasing hormone agonist or human chorionic gonadotropin. Biochem. Biophys. Res. Commun., 76, 855
Auclair, C., Kelly, P. A., Coy, D. H., Schally, A. V. and Labrie, F. (1977). Potent inhibitory activity of [D-Leu6, des-Gly-NH2 10]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat. Endocrinology, 101, 1890
Labrie, F., Auclair, C., Cusan, L., Kelly, P. A., Pelletier, G. and Ferland, L. (1978). Inhibitory effects of LHRH and its agonists on testicular gonadotropin receptors and spermatogenesis in the rat. In Hansson, V. (ed.). Endocrine Approach to Male Contraception. Int. J. Androl. (Suppl.), 2, 303
Labrie, F., BĂ©langer, A., Cusan, L., et al. (1980). Antifertility effects of LHRH agonists in the male. J. Androl., 1, 209
Pelletier, G., Cusan, L., Auclair, C., Kelly, P. A., DĂ©sy, L. and Labrie, F. (1978). Inhibition of spermatogenesis in the rat by treatment with [D-Ala6, des-GlyNH211LHRH ethylamide. Endocrinology, 103, 641
Sandow, J., Von Rechenberg, W. V., Konig, W., Hahn, M., Jerzabek, G. and Fraser, H. (1978). Physiological studies with highly active analogue of LHRH. In Gupta, D. and Voelter, W. (eds.). Hypothalamic Hormones — Chemistry, Physiology and Clinical Applications, pp. 307–326. ( Berlin: Verlag Chemie )
Tcholakian, R. K., De la Cruz, A., Chowdhury, M., Steinberger, A., Coy, D. H. and Schally, A. V. (1978). Unusual anti-reproductive properties of the analog (DLeu6, des-Gly-NH211LHRH ethylamide in male rats. Fertil. Steril., 30, 600
Rivier, C., Rivier, J. and Vale, W. (1979). Chronic effects of [D-Trp6, Pro9, NEt]LHRH on reproductive processes in the male rat. Endocrinology, 105, 1191
Cusan, L., Auclair, C., Bélanger, A., et al. (1979). Inhibitory effects of long-term treatment with an LHRH agonist on the pituitary—gonadal axis in male and female rats. Endocrinology, 104, 1369
Arimura, A., Serafini, P., Talbot, S. and Schally, A. V. (1979). Reduction of testicular luteinizing hormone/human chorionic gonadotropin receptors by [DTrp6]luteinizing hormone-releasing hormone in hypophysectomized rats. Biochem. Biophys. Res. Commun., 90, 687
Catt, K. J., Baukal, A. J., Davies, T. F. and Dufau, M. L. (1979). Luteinizing hormone-releasing hormone-induced regulation of gonadotropin and prolactin receptors in the rat testis. Endocrinology, 104, 17
BĂ©langer, A., Auclair, C., Ferland, L., Caron, S. and Labrie, F. (1980). Time-course of the effect of treatment with a potent LHRH agonist on testicular steroidogenesis and gonadotropin receptor levels in the adult rat. J. Steroid Biochem., 13, 191
BĂ©langer, A., Cusan, L., Auclair, C., SĂ©guin, C., Caron, S. and Labrie, F. (1980). Effect of an LHRH agonist and hCG on testicular steroidogenesis in the adult rat. Biol. Reprod., 22, 1094
Hsueh, A. J. W. and Erickson, G. F. (1979). Extrapituitary inhibition of testicular function by luteinizing hormone-releasing hormone. Nature (Lond.), 281, 66
Lefebvre, F. A., Reeves, J. J., SĂ©guin, C., Massicotte, J. and Labrie, F. (1980). Specific binding of a potent LHRH agonist in rat testis. Mol. Cell. Endocrinol., 20, 127
Perrin, N. H., Vaughan, J. M., Rivier, J. E. and Vale, W. W. (1980). High affinity GnRH binding to testicular membrane homogenates. Life Sci., 26, 2251
SĂ©guin, C., BĂ©langer, A., Cusan, L., et al. (1981). Relative importance of the adenohypophyseal and gonadal sites of inhibitory action of LHRH agonists. Biol. Reprod., 24, 889
SĂ©guin, C., BĂ©langer, A., Labrie, F. and Hansel, W. (1982). Study of the direct action of luteinizing hormone-releasing hormone agonists at the testicular level in intact rats treated with an antiluteinizing hormone serum. Endocrinology, 110, 524
Sandow, J. and Hahn, M. (1978). Chronic treatment with LHRH in golden hamsters. Acta Endocrinol., 88, 601
Resko, J., BĂ©langer, A. and Labrie, F. (1982). Effects of chronic treatment with a potent LHRH agonist on serum LH and steroid levels in the male rhesus monkey. Biol. Reprod., 26, 378
BĂ©langer, A., Labrie, F., Lemay, A., Caron, S. and Raynaud, J. P. (1980). Inhibitory effects of a single intranasal administration of [D-ser(TBU)6, des-Gly-NH210]LHRH ethylamide on serum steroid levels in normal adult men. J. Steroid Biochem., 13, 113
Labrie, F., Dupont, A., BĂ©langer, A., et al. (1982). New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen. J. Clin. Invest. Med., 5, 267
Labrie, F., Dupont, A., BĂ©langer, A., et al. (1983). New approach in the treatment of prostate cancer: complete instead of only partial withdrawal of androgens. Prostate (In press)
Faure, N., Labrie, F., Lemay, A., et al. (1982). Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men. Fertil. Steril., 37, 416
Tolis, G., Ackman, D., Stellos, A., et al. (1982). Tumor growth inhibition in patients with prostatic carcinoma treated with agonists of LHRH. Proc. Natl. Acad. Sci. USA, 79, 1658
Crowley, W. F., Jr., Comite, F., Vale, W., Rivier, J., Loriaux, D. L. and Cutler, G. B., Jr. (1981). Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty. J. Clin. Endocrinol., 52, 370
Carmichael, R., BĂ©langer, A., Cusan, L, SĂ©guin, C., Caron, S. and Labrie, F. (1980). Increased testicular 5a-androstane-3a, 17/3-diol formation induced by treatment with [D-Ser(TBU)6, des-Gly-NH210]LHRH ethylamide in the rat. Steroids, 36, 383
Linde, R., Doelle, G., Alexander, N., et al. (1981). Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men. N. Engl. J. Med., 305, 663
National Coordinating Group on Male Antifertility Agents (1978). Gossypol — a new antifertility agent for males. Clin. Med. J. (Engl.), 4, 417
Djerasi, C. (1980). The politics of contraception. In Norton, W. W. (ed.). Djerasi, C. 183–213. ( New York )
Schearer, S. B., Alvarez-Sanchez, F., Anselmo, J., et al. (1978). Hormonal contraception for men. Int. J. Androl. Suppl., 2, 680
Lee, H. Y., Kim, S. I. and Kwon, E. H. (1979). Clinical trial of reversible male contraception with long-acting sex hormones. Scand. J. Med., 20, 1
Huggins, C. and Hodges, C. V. (1941). Studies of prostatic cancer. I. Effect of castration, estrogen and androgen injections on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res., 1, 293
Bailer, J. C., Byar, D. P. and Veterans Administration Cooperative Urology Research Group (1970). Estrogen treatment for cancer of the prostate. Cancer, 26, 257
Glode, L. M. (Abbott Prostatic Cancer Study) (1982). Leuprolide therapy of advanced prostatic cancer. ASCO Proceedings, Abstract, p. 110
Lefebvre, F. A., SĂ©guin, C., BĂ©langer, A. et al. (1982). Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat. Prostate, 3, 569
Kelly, S., Labrie, F. and Dupont, A. (1983). Loss of LH bioactivity in men treated with an LHRH agonist and an antiandrogen. Proceedings of the 65th Annual Meeting of the Endocrinology Society, p. 81
Sanford, E. J., Paulson, D. F., Rohner, T. J., et al. (1977). The effects of castration on adrenal testosterone secretion in men with prostatic carcinoma. J. Urol., 118, 1019
Bhanalaph, T., Varkarakis, M. J. and Murphy, G. P. (1974). Current status of bilateral adrenalectomy of advanced prostatic carcinoma. Ann. Surg., 179, 17
Geller, J., Albert, J., Loza, D., Geller, S., Stoeltzing, W. and De La Vega, D. (1978). DHT concentrations in human prostate cancer tissue. J. Clin. Endocrinol. Metab., 46, 440
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 MTP Press Limited
About this chapter
Cite this chapter
Labrie, F., BĂ©langer, A., Dupont, A., St-Arnaud, R. (1984). Medical castration in men: the first clinical application of LHRH agonists. In: Harrison, R.F., Bonnar, J., Thompson, W. (eds) Fertility and Sterility. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-1308-1_3
Download citation
DOI: https://doi.org/10.1007/978-94-015-1308-1_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-015-1310-4
Online ISBN: 978-94-015-1308-1
eBook Packages: Springer Book Archive